We next tested the ability of α4+/CD4+ spleen T-cells to cause diabetes, with a most remarkable outcome: all NOD hosts developed diabetes, as before with very short latency, while NOD.α4-/- recipients were completely protected (Figure 1E; p < 0.01). This evidence concerns the gene CD4 and diabetes mellitus.